[210 Pages Report] The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 349.9 Million in 2017, at a CAGR of 8.4%. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

The objectives of this study are as follows:

To define, describe, and forecast the global creatinine measurement on the basis of type, type of sample, end user, product and region

To estimate the total number of creatinine measurement tests conducted by type and region.

To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)

To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders

To forecast the size of the market with respect to five regions: North America, Europe, Asia, and the Rest of the World (RoW)

To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies

To track and analyze competitive developments in the creatinine measurement market, such as acquisitions, agreements, product launches & upgrades, expansions, and R&D activities

Research Methodology

The study estimates the creatinine measurement market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include physicians/doctors, healthcare professionals, clinical laboratory executives, lab managers, laboratory assistants, and biochemistry consultants.

For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the creatinine measurement market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Secondary sources such as directories; databases such as D&B Hoovers, Bloomberg Business, and Factiva; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies were referred.

To know about the assumptions considered for the study, download the pdf brochure

The creatinine measurement market is highly fragmented with the presence of several small and big players. The prominent players in this market include F. Hoffmann-la Roche ltd. (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific (US), Siemens Healthineers (Germany), Randox Laboratories (UK), Pointe Scientific (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

Target Audience for this Report:

Creatinine test kits and reagents manufacturers

Creatinine test kits and reagents distributors

Hospitals

Research and consulting firms

Venture capitalists

Regulatory bodies

Academic centers

Teaching hospitals and academic medical centers (AMCs)

Contract manufacturing organizations (CMOs)

Contract research organizations (CROs)

Scope of the Report

This report categorizes the creatinine measurement market into following segments and subsegments:

Creatinine Measurement Market, by Type

Jaffe�s kinetic method

Enzymatic method

Creatinine Measurement Market, by Type of Sample

Blood/serum

Urine

Creatinine Measurement Market, by End user

Hospitals

Diagnostic Laboratories

Creatinine Measurement Market, by Product

Reagents

Kits

Creatinine Measurement Market, by Region

North America US Canada

Europe Germany UK France RoE

Asia Japan China India Indonesia RoA

Rest of the World (RoW) Brazil Other Rest of the World



Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives.

This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type, the market is segmented into Jaffe�s kinetic method and enzymatic method. In 2018, the Jaffe�s kinetic method segment is estimated to account for the largest share of the creatinine measurement market, as it is the oldest and most conventional method for creatinine measurement in clinical samples. Additionally, the widespread availability and cost-effectiveness of kits and reagents used in Jaffe�s kinetic method is another major factor responsible for the large share of this segment.

Based on type of sample, the market is segmented into blood/serum and urine samples. The blood sample segment accounted for the largest share of the creatinine measurement market in 2017 due to the increased accuracy and low risk of contamination. This segment is also expected to witness the highest growth over the forecast period, as it is the most preferred sample type for accurate measurement of creatinine levels.

Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement owing to established infrastructures with an advanced diagnostic assembly for better diagnostic results within shorter time spans. The diagnostic laboratories segment is expected to witness the highest growth over the forecast period as various market players are entering into long-term collaborations with diagnostic laboratories in order to increase their presence in the creatinine measurement market.

In 2017, North America dominated the market followed by Europe. Asia is expected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as the growing prevalence of CKD, rising awareness about preventive healthcare, improving healthcare infrastructure, and growing focus of market players on addressing the demands in several Asian countries. Also, as developed markets are reaching saturation levels, Asia is expected to become a hotspot for creatinine kits and reagents providers However, identification of novel renal dysfunction Biomarkers and frequently changing regulatory policies are expected to challenge market growth in the coming years.

The creatinine measurement market is highly fragmented with the presence of several small and big players. The prominent players in this market include F. Hoffmann-la Roche Ltd (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific (US), Siemens Healthineers (Germany), Randox Laboratories (UK), Pointe Scientific (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst